EDETOX logo

IN VIVO STUDIES FURTHER DETAILS

In Vivo Study No: 777

METHODS

Chemical	Membrane	Concentration mg/ml	Concentration mg/ml	loading (mg/cm2)	Species	Site	Area (cm2)	Occluded?	Exposure Time (h)	Analytical Method
Testosterone	Not Given		0.004	Acetone	Human	Ventral Forearm		2	24	Radiolabelled (14C)

RESULTS

Length of Study (h)	% Recovery	+/-	Dose remaining on surface (mg)	% remaining on Surface	Dose remaining in stratum corneum (mg)	% remaining in stratum corneum	Dose remaining in the viable skin	% remaining in the viable skin	Amount Absorbed (mg)	% Absorbed	+/-	% Absorbed
120										13.2	3	13.2

Length of Study (h)

% Recovery

+/-

Dose remaining on surface (mg)

% remaining on Surface

Dose remaining in stratum corneum (mg)

% remaining in stratum corneum

Dose remaining in the viable skin

% remaining in the viable skin

Amount Absorbed (mg)

% Absorbed

+/-

% Absorbed

120

13.2

Maximal Flux (mcrg/cm2/h)	Average Flux (mcrg/cm2/h)	+/-	Time Plasma/Blood Levels Peaked (h)	Peak Blood Concentration (mg/l)	n	kp (cm/h)	Lag Time (h)
					17

NOTES

18-35 year old volunteers took part in this study. The subjects were all in good health, non-smokers and absent of any obvious skin disease. Percutaneous Absorption was quantified by the amount of the substance excreted in the urine over 5 days, corrected for incomplete absorption by a parenteral correction factor.

REFERENCE

Percutaneous Absorption In The Aged (1986) Dermatologic Clinics, 4 :455-465